A previously described cold-adapted attenuated virus, A/Leningrad/134/17/57(H2N2), was further modified by 30 additional passages in chicken embryos at 25°C. This virus had a distinct temperaturesensitive (ts) phenotype, grew well in chicken embryos at 25°C, and failed to recombine with reference ts mutants of fowl plague virus containing ts lesions in five genes coding for non-glycosylated proteins (genes 1, 2, 5, 7, and 8 Previously we obtained a cold-adapted attenuated influenza A virus strain, A/Leningrad/134/17/57(H2N2), containing temperature-sensitive (ts) mutations in three genes (4). Recombinant, cold-adapted, live attenuated influenza vaccines (H3N2 and H1N1) were prepared and evaluated in adults. The recombinant vaccine strains were characterized by low reactogenicity and high antigenic activity (1, 3, 4, 6) .
Previously we obtained a cold-adapted attenuated influenza A virus strain, A/Leningrad/134/17/57(H2N2), containing temperature-sensitive (ts) mutations in three genes (4) . Recombinant, cold-adapted, live attenuated influenza vaccines (H3N2 and H1N1) were prepared and evaluated in adults. The recombinant vaccine strains were characterized by low reactogenicity and high antigenic activity (1, 3, 4, 6) .
In the present study we attempted to obtain a stable, attenuated, cold-adapted vaccine suitable for use in children 3 to 15 years old by (i) further passaging the A/Leningrad/ 134/17/57 strain until a majority of the genes which code for non-glycosylated proteins might have ts mutations; (ii) preparing recombinants of this donor with wild-type influenza virus strains of HlNl and H3N2 serotypes and demonstrating that the recombinants inherited the majority of the genes from the attenuated donor, but that the hemagglutinin and neuraminidase genes were from the wild-type strains; and (iii) determining reactogenicity and antigenic activity of these recombinant vaccines in children 3 to 15 years of age. This paper presents data on obtaining a cold-adapted donor strain and cold-adapted recombinants, on determination of genes of the donor strain which carry ts mutations, and on analysis of the genome composition of the recombinants obtained.
MATERIALS AND METHODS
Viruses. The cold-adapted A/Leningrad/134/17/57(H2N2) strain (1, 4, 6) to the donor strain A/Leningrad/134/47/57. The selected recombinant was designated 47/25/1(HlN1).
Recombination test. The analysis of the attenuated donor strain and the recombinants was carried out by recombination test. This was done in chicken embryo fibroblast (CEF) cultures or, in some experiments, in the MDCK cell line, using reference ts mutants of FPV belonging to different recombination groups in which the genes carrying a ts mutation were previously determined. The viruses and method used in these experiments were described earlier (4).
Determination of the genome composition of recombinants. The genome composition of the recombinants was analyzed by hybridization of labeled viral cRNA with unlabeled virion RNA, followed by treatment of double-stranded complexes with nuclease Si and polyacrylamide gel electrophoresis (4, 5) . RESULTS Examination of ts phenotype. Wild-type parent strains grew well at 40°C, but failed to reproduce at 25°C (Table 1) . 
At the same time, the cold-adapted parent and both recombinants possessed a distinct ts40 phenotype but were able to grow well at 250C.
The cold-adapted A/Leningrad/134/47/57 strain, which had had 47 passages in chicken embryos at 25°C, did not recombine in CEF culture with FPV mutants ts29, ts131, tsUS1, ts303/1, and tsmN3, which have ts lesions in genes 1, 2, 5, 7, and 8, respectively (Table 2) . Therefore, it is likely that five of six nonglycosylated viral proteins (PB1, PB2, NP, M, and NS) of A/Leningrad/134/47/57 contain ts mutations.
Since there are data in the literature concerning dependence of manifestation of the ts phenotype of influenza virus on the host-cell (td-hr mutants) (10), we performed a recombination analysis of cold-adapted donor with FPV ts mutants in mammalian cell line MDCK (dog kidney cells). The data obtained turned out to be identical to those obtained in CEF culture (Table 3) . It should be noted that all ts mutants of the FPV Weybridge strain (H7N7) reproduced and formed plaques in MDCK culture.
Genome composition of the recombinants obtained between the cold-adapted donor and actual wild-type influenza virus strains. Recombinant 47/25/1(HlN1) was shown by RNA hybridization and nuclease digestion to inherit genes 2, 3, 5, 7, and 8 from the cold-adapted parent, but gene 1 and two genes coding for the hemagglutinin and neuraminidase glycoproteins were from the wild-type strain ( Fig. 1 and Table 4 ). Recombinant 47/7/2(H3N2) was similarly shown to inherit all the genes coding for nonglycosylated proteins (1, 2, 3, 5, 7 , and 8) from the cold-adapted parent, and only genes 4 and 6, which code for hemagglutinin and neuraminidase, respectively, were from the wild-type strain ( Fig. 1 and Table 4 ). they caused no vaccination reactions even after intranasal immunization of doubly seronegative individuals who lacked both anti-hemagglutinin and anti-neuraminidase antibody in their serum (4, 6, 7) . However, since children, particularly of preschool age, are highly susceptible to influenza illness, we decided to prepare a special donor of attenuation which could be used to construct recombinant live vaccine strains for children. After 30 additional passages of the cold-adapted A/Leningrad/134/17/57 strain at 25°C, we obtained the A/ Leningrad/134I47/57 variant. Analysis of this variant in chicken embryos at 25°C in a test of recombination, in CEF culture, or in the MDCK cell line with reference FPV ts mutants with known genes carrying mutation lesions showed that the variant obtained fails to recombine with ts mutants with mutations in genes 1, 2, 5, 7, and 8. These data suggest that this variant has mutations in the genes coding for nonglycosylated proteins (PB1, PB2, NP, M, and NS). Taking into account, however, that the analysis of data obtained by a recombination test may be complicated by such phenomenum as extragenic suppression or intragenic complementation, definitive proof of the site of ts mutations will require further detailed genetic and molecular analysis. 
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The analysis of the genome composition of the recombinants obtained by recombination of the cold-adapted donor with wild-type influenza virus strains A/Bangkok/l/ 79(H3N2) and A/Leningrad/322/79(HlN1) showed that recombinant 47/7/2(H3N2) inherited all six genes coding for non-glycosylated proteins from the cold-adapted donor and the genes coding for hemagglutinin and neuraminidase from the wild-type strain; recombinant 47/25/1(HlN1) inherited five genes from the cold-adapted parent, whereas gene 1 and the genes coding for the hemagglutinin and neuraminidase were derived from the wild-type strain. Both recombinants retained a ts phenotype identical to that of the coldadapted donor strain.
As shown in a companion paper (2), the recombinants obtained proved to be weakly reactogenic for children of 3 to 15 years of age but possessed high antigenic activity and genetic stability.
